Calfactant

卡法克坦

Report date: 2025/07/15 17:47:08

Base Information

Drug NameCalfactant
Drug Alias Name卡尔法坦Infasurf
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsIntraoperative ComplicationsPerinatal DeathRespiratory Distress Syndrome, Newborn +[6] 
Global Approved IndicationsRespiratory Distress Syndrome, Adult
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/07/01
Country/TerritoryCanadaUnited StatesNew Zealand +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesOny, Inc
Inactive CompaniesPneuma Pharmaceuticals, IncNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsIntraoperative ComplicationsPerinatal DeathRespiratory Distress Syndrome, Newborn +[4] 
Inactive IndicationsBronchopulmonary DysplasiaBronchiolitis

Other Information

ATC CodeR07AX
Related LinksWikipediaDrugBankKEGG